Bayer announced today the start of its Phase III study SUNFLOWER, an investigational study evaluating the efficacy and safety ...

Bayer has started a phase 3 trial of its intrauterine contraceptive Mirena in an endometrial condition that can lead to ...

Berlin: Bayer has announced the clinical Phase III study SUNFLOWER with its 52mg levonorgestrel-releasing intrauterine system ...

Bayer (BAYRY) announced the start of its Phase III study SUNFLOWER, an investigational study evaluating the efficacy and safety of 52mg ...

Ontada®, a McKesson business dedicated to real-world oncology data and insights, will present findings from a retrospective cohort study at the 67th American Society of Hematology (ASH) Annual Meeting ...

Orsini, a leader in rare disease pharmacy solutions, announced today that it is a specialty pharmacy partner for ITVISMA® (onasemnogene abeparvovec-brve), an FDA-approved intrathecal gene therapy for ...

Sebaceous hyperplasia is a harmless skin condition involving the overgrowth or enlargement of the sebaceous glands. Sebaceous glands are attached to hair follicles all over your body. They release ...

Sophia Harris first got on birth control pills at age 10 to manage “out of control” hormone fluctuations. Harris, 27, stayed ...

CARE Hospitals is a part of Quality Care India Ltd. (QCIL), backed by Blackstone, with the vision to become the largest hospital chain in India through continuous investments in Talent, Technology, ...

Hyderabad: In what senior clinicians described as “a deeply meaningful day for women’s health,” CARE Hospitals, Banjara Hills ...

The role of biomechanical cues in the progression of PM2.5-induced corneal disease was investigated, and PAI-2 was identified ...